Consistent with theoretical expectations, as an MMP inhibitor, TIMP2 was downregulated in many cancer types, and its high expression may indicate a better prognosis (Stetler-Stevenson and Gavil, 2014; Wang et al., 2021; Wang and Liu, 2021). Here, TIMP2 is linked to cancer.